JIANGSU HONGHUI PHARMACEUTICAL CO.,LTD. was established in Feb. 1998. Before its establishment Honghui was the New Drugs Department Agency of Jiangsu Medical Co., Ltd., a state-owned enterprise. Now Honghui has developed into an integrated company dealing with research & development, production, distribution and marketing.

Our R&D department collaborates with domestic leading institutes with focus on innovative new drugs with a bright future; Jiangsu Shenlong Pharmaceutical Co., Ltd., our subsidiary company with a GMP certificate, is in the position to supply more than 100 products in different specifications and dosage forms such as Infusion solutions, Injections, Capsules, Tablets, Granules, Pharmaceutical Intermediates & Raw materials and so on.

Concerning marketing, we attach same importance to vicegerent products and our own drugs. The best selling product lines are as below:

Cardiovascular products

Oncological products

Orthopedic product

Gynecological products

Our sales network has a service covering all through the country; meanwhile, we have established long-term consigned relations with 4 pharmaceutical giants in China.

Honghui has been enjoying rapid expansion since its establishment. We are extending international commerce and are glad to cooperate with foreign enterprises. We would be glad to be your reliable partner in China.Economic function

　　 distribution of drugs

　　- research & development

　　- production & manufacture

Headquarter:

　　Nanjing City , Jiangsu Province, ChinaThree distribution companies in two provinces

　　- East China/ two in Jiangsu Province (73 million people)

　　- South China / one in Hainan Province

Honghui’s areas of distribution

Distribution for fifteen important Chinese companies, and their twenty-two products

Total provinces in China: 29

Coverage by Honghui: 28